{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:18:15Z","timestamp":1788499095868,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are surrogate markers of the systemic immune-inflammatory response proposed as perioperative prognostic biomarkers in epithelial ovarian cancer (EOC), yet their performance across subgroups remains unexamined. In 373 EOC patients undergoing primary cytoreductive surgery, postoperative day-1 changes (\u0394SII, \u0394NLR, \u0394PLR) were compared for overall survival (OS) and progression-free survival (PFS) across 10 subgroups, and a Clinical-Inflammatory Risk Score (CIRS) combining inflammation with stage and residual disease was developed. Individual markers showed modest discrimination (area under the curve [AUC] 0.579\u20130.615); the marker with the highest AUC varied by context, with \u0394PLR ranking first most often, notably in non-serous tumors, though none was statistically superior. Seeking a molecular counterpart, two public transcriptomic cohorts were re-analyzed: VWF was consistently higher in clear cell than serous carcinoma, whereas IL6\u2013STAT3-related differences were cohort-dependent. The CIRS achieved AUCs of 0.752 (OS) and 0.764 (PFS), a six-fold mortality gradient (7.2% vs. 44.4%), and remained independently associated with OS and PFS (hazard ratio 2.55 and 2.24 per standard deviation), though discrimination was not significantly better than stage and residual disease alone. These biomarkers show subgroup-dependent prognostic value, and the CIRS provides an exploratory risk-stratification framework warranting prospective validation.<\/jats:p>","DOI":"10.3390\/ijms27177777","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"7777","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Immune-Inflammatory Biomarkers in Epithelial Ovarian Cancer: Subgroup-Dependent Prognostic Performance and Integrated Risk Stratification"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-5860","authenticated-orcid":false,"given":"E Sun","family":"Paik","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3904-8120","authenticated-orcid":false,"given":"Young Eun","family":"Chung","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung","family":"Youn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1174-1344","authenticated-orcid":false,"given":"Seongyun","family":"Lim","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-3084","authenticated-orcid":false,"given":"Jun-Hyeong","family":"Seo","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chel Hun","family":"Choi","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-9164","authenticated-orcid":false,"given":"Tae-Joong","family":"Kim","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-4909","authenticated-orcid":false,"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-9877","authenticated-orcid":false,"given":"Yoo-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Pothuri","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0889-1591(02)00063-6","article-title":"The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology","volume":"17","year":"2003","journal-title":"Brain Behav. Immun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","article-title":"Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells","volume":"73","author":"Tai","year":"2013","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1245\/ASO.2003.02.007","article-title":"Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?","volume":"10","author":"Shakhar","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"112317","DOI":"10.1016\/j.isci.2025.112317","article-title":"Evolution of tumor stress response during cytoreductive surgery for ovarian cancer","volume":"28","author":"Praiss","year":"2025","journal-title":"iScience"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Oncul, S., and Cho, M.S. (2023). Interactions between platelets and tumor microenvironment components in ovarian cancer and their implications for treatment and clinical outcomes. Cancers, 15.","DOI":"10.3390\/cancers15041282"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00262-008-0516-3","article-title":"Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment","volume":"58","author":"Cho","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kovacs, A.R., Sulina, A., Kovacs, K.S., Lukacs, L., Torok, P., and Lampe, R. (2023). Prognostic significance of preoperative NLR, MLR, and PLR values in predicting the outcome of primary cytoreductive surgery in serous epithelial ovarian cancer. Diagnostics, 13.","DOI":"10.3390\/diagnostics13132268"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13048-025-01626-1","article-title":"Prognostic significance of systemic immune inflammation index for ovarian cancer: An updated systematic review and meta-analysis","volume":"18","author":"Chu","year":"2025","journal-title":"J. Ovarian Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Plaja, A., Teruel, I., Ochoa-de-Olza, M., Cucurull, M., Arroyo, \u00c1.J., Pardo, B., Ortiz, I., Gil-Martin, M., Piulats, J.M., and Pla, H. (2023). Prognostic role of neutrophil, monocyte and platelet to lymphocyte ratios in advanced ovarian cancer according to the time of debulking surgery. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411420"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00404-018-4678-8","article-title":"Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: A meta-analysis of retrospective studies","volume":"297","author":"Zhao","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2017.08.004","article-title":"An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology\/Gynecologic Oncology Group experience","volume":"147","author":"Oliver","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Pappa, C., Aggarwal, A., El Tawab, S., Sattar, A., Damato, S., Sadeghi, N., and Soleymani Majd, H. (2025). Clinicopathological characteristics and oncologic outcomes of endometrioid ovarian carcinoma: A retrospective study from a tertiary cancer centre. Biomedicines, 13.","DOI":"10.3390\/biomedicines13102381"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-05-3694","article-title":"Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas","volume":"66","author":"Hendrix","year":"2006","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/onc.2013.307","article-title":"COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer","volume":"33","author":"Wu","year":"2014","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.18632\/oncotarget.7277","article-title":"Association and prognostic significance of BRCA1\/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1\/PD-L1 in high grade serous ovarian cancer","volume":"7","author":"Strickland","year":"2016","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10147-022-02272-z","article-title":"The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer","volume":"28","author":"Bizzarri","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1158\/1078-0432.CCR-10-3314","article-title":"IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer","volume":"17","author":"Anglesio","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/jth.14976","article-title":"Von Willebrand factor and cancer; metastasis and coagulopathies","volume":"18","author":"Patmore","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ivanova, T.I., Klabukov, I.D., Krikunova, L.I., Poluektova, M.V., Sychenkova, N.I., Khorokhorina, V.A., Vorobyev, N.V., Gaas, M.Y., Baranovskii, D.S., and Goryainova, O.S. (2022). Prognostic value of serum transferrin analysis in patients with ovarian cancer and cancer-related functional iron deficiency: A retrospective case\u2013control study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247377"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chung, Y.E., Paik, E.S., Kim, M., Choi, C.H., Kim, T.-J., Lee, J.-W., and Lee, Y.-Y. (2025). Prognostic impact of postoperative systemic immune-inflammation index changes in epithelial ovarian cancer. Cancers, 17.","DOI":"10.3390\/cancers17213422"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/sim.4780132307","article-title":"Penalized likelihood in Cox regression","volume":"13","author":"Verweij","year":"1994","journal-title":"Stat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bimj.200900028","article-title":"L1 penalized estimation in the Cox proportional hazards model","volume":"52","author":"Goeman","year":"2010","journal-title":"Biom. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7777\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:43:42Z","timestamp":1788497022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":30,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177777"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177777","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]}}}